Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Onconetix Inc (ONCO)

Onconetix Inc (ONCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,726
  • Shares Outstanding, K 22,328
  • Annual Sales, $ 60 K
  • Annual Income, $ -37,410 K
  • 60-Month Beta 3.38
  • Price/Sales 45.03
  • Price/Cash Flow N/A
  • Price/Book 1.61
Trade ONCO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.89
  • Most Recent Earnings $-0.28 on 11/17/23
  • Latest Earnings Date 05/10/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.16
  • Growth Rate Est. (year over year) +624,475.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1001 +20.28%
on 04/23/24
0.2500 -51.84%
on 04/08/24
-0.0423 (-26.00%)
since 03/25/24
3-Month
0.1001 +20.28%
on 04/23/24
0.2583 -53.39%
on 01/26/24
-0.2196 (-64.59%)
since 01/25/24
52-Week
0.1001 +20.28%
on 04/23/24
1.5800 -92.38%
on 06/14/23
-0.9196 (-88.42%)
since 04/25/23

Most Recent Stories

More News
Oncopeptides Chief Financial Officer Holger Lembrer takes office today

/PRNewswire/ -- Oncopeptides AB (publ.) (NASDAQ Stockholm: ONCO), a biotech company focused on commercialization, research, and development of therapies for...

ONCO : 0.1204 (-1.39%)
Oncopeptides appoints Holger Lembrer as Chief Financial Officer

/PRNewswire/ -- Oncopeptides AB (publ.) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat...

ONCO : 0.1204 (-1.39%)
Monica Shaw appointed CEO of Oncopeptides - Jakob Lindberg assumes position as Chief Scientific Officer

/PRNewswire/ -- Oncopeptides AB (publ.) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat...

ONCO : 0.1204 (-1.39%)
Oncopeptides has announced the Nomination Committee

/PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO). According to the principles for the appointment of the Nomination Committee in Oncopeptides AB...

ONCO : 0.1204 (-1.39%)
Oncopeptides presents new scientific data at the Annual American Society of Hematology Meeting ASH

/PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat...

ONCO : 0.1204 (-1.39%)
Oncopeptides provides update on Pepaxto US marketing authorization

/PRNewswire/ -- Oncopeptides AB (publ) (NASDAQ Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat...

ONCO : 0.1204 (-1.39%)
Oncopeptides enters into a renewed loan facility agreement of up to €30 million with the European Investment Bank

/PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat...

ONCO : 0.1204 (-1.39%)
Oncopeptides' Pepaxti has been granted marketing authorization in the UK

/PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat...

ONCO : 0.1204 (-1.39%)
Oncopeptides publishes Q3 report 2022

/PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat...

ONCO : 0.1204 (-1.39%)
Oncopeptides announces the market potential for Pepaxti in Europe

/PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat...

ONCO : 0.1204 (-1.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Onconetix Inc. is a commercial stage biotechnology company focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. Onconetix Inc., formerly known as Blue Water Biotech Inc., is based in CINCINNATI.

See More

Key Turning Points

3rd Resistance Point 0.1413
2nd Resistance Point 0.1342
1st Resistance Point 0.1273
Last Price 0.1204
1st Support Level 0.1133
2nd Support Level 0.1062
3rd Support Level 0.0993

See More

52-Week High 1.5800
Fibonacci 61.8% 1.0147
Fibonacci 50% 0.8401
Fibonacci 38.2% 0.6654
Last Price 0.1204
52-Week Low 0.1001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar